Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
Tema
Enfermedad de Parkinson
2346 ARTíCULOS , VIENDO DEL 1 AL 15
Clozapine Therapy and CYP Genotype
Dean L, Kane M.
2016 Jun 8 [updated 2021 May 26]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.
0
0
0
Using stem cells and iPS cells to discover new treatments for Parkinson's disease.
Cooper O, Hallett P, Isacson O.
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S14-6. doi: 10.1016/S1353-8020(11)70007-4. Review.
0
0
0
Puschmann A, Englund E, Ross OA, Vilariño-Güell C, Lincoln SJ, Kachergus JM, Cobb SA, Törnqvist AL, Rehncrona S, Widner H, Wszolek ZK, Farrer MJ, Nilsson C.
Parkinsonism Relat Disord. 2012 May;18(4):332-8. doi: 10.1016/j.parkreldis.2011.11.019.
0
0
0
Targeting mitochondria for neuroprotection in Parkinson's disease.
Schapira AH.
Antioxid Redox Signal. 2012 May 1;16(9):965-73. doi: 10.1089/ars.2011.4419. Review.
0
0
0
Plotnik M, Giladi N, Hausdorff JM.
Parkinsons Dis. 2012;2012:459321. doi: 10.1155/2012/459321.
0
0
0
Monteiro L, Souza-Machado A, Valderramas S, Melo A.
Clin Ther. 2012 May;34(5):1049-55. doi: 10.1016/j.clinthera.2012.03.001. Review.
0
0
0
Schillaci O, Chiaravalloti A, Pietro BD, Stefani A.
Hell J Nucl Med. 2012 Jan-Apr;15(1):74-5. No abstract available.
0
0
0
Hemispheric asymmetries and prosodic emotion recognition deficits in Parkinson's disease.
Ventura MI, Baynes K, Sigvardt KA, Unruh AM, Acklin SS, Kirsch HE, Disbrow EA.
Neuropsychologia. 2012 Jul;50(8):1936-45. doi: 10.1016/j.neuropsychologia.2012.04.018.
0
0
0
A large study reveals no association between APOE and Parkinson's disease.
Federoff M, Jimenez-Rolando B, Nalls MA, Singleton AB.
Neurobiol Dis. 2012 May;46(2):389-92. doi: 10.1016/j.nbd.2012.02.002.
0
0
0
Caffeine intake, smoking, and risk of Parkinson disease in men and women.
Liu R, Guo X, Park Y, Huang X, Sinha R, Freedman ND, Hollenbeck AR, Blair A, Chen H.
Am J Epidemiol. 2012 Jun 1;175(11):1200-7. doi: 10.1093/aje/kwr451.
0
0
0
Brain transcriptomic profiling in idiopathic and LRRK2-associated Parkinson's disease.
Botta-Orfila T, Sànchez-Pla A, Fernández M, Carmona F, Ezquerra M, Tolosa E.
Brain Res. 2012 Jul 23;1466:152-7. doi: 10.1016/j.brainres.2012.05.036.
0
0
0
New-onset Parkinson syndrome after liver transplantation.
Rifaie N, Koeppen S, Treckmann JW, Paul A, Saner FH.
Transplantation. 2012 Oct 27;94(8):e56-7. doi: 10.1097/TP.0b013e31826b85c9. No abstract available.
0
0
0
Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease.
Greggio E.
Biochem Soc Trans. 2012 Oct;40(5):1058-62. Review.
0
0
0
Xie T, Kang UJ, Warnke P.
J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):1015-7. doi: 10.1136/jnnp-2011-302091.
0
0
0
An exercise intervention to prevent falls in Parkinson's: an economic evaluation.
Fletcher E, Goodwin VA, Richards SH, Campbell JL, Taylor RS.
BMC Health Serv Res. 2012 Nov 23;12:426. doi: 10.1186/1472-6963-12-426.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
